These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 25339485)

  • 1. The role of spironolactone in the metabolism of serum type I collagen in elderly patients with atrial fibrillation.
    Zhang SH; Wang J; Jin TR; Zhang LX; Shao J
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2903-7. PubMed ID: 25339485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
    Ravassa S; Trippel T; Bach D; Bachran D; González A; López B; Wachter R; Hasenfuss G; Delles C; Dominiczak AF; Pieske B; Díez J; Edelmann F
    Eur J Heart Fail; 2018 Sep; 20(9):1290-1299. PubMed ID: 29709099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
    Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and biomarkers of myocardial fibrosis in heart failure.
    Löfsjögård J; Persson H; Díez J; López B; González A; Edner M; Mejhert M; Kahan T
    Scand Cardiovasc J; 2014 Oct; 48(5):299-303. PubMed ID: 24978653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation.
    Swartz MF; Fink GW; Sarwar MF; Hicks GL; Yu Y; Hu R; Lutz CJ; Taffet SM; Jalife J
    J Am Coll Cardiol; 2012 Oct; 60(18):1799-806. PubMed ID: 23040566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
    Kobayashi M; Girerd N; Ferreira JP; Kevin D; Huttin O; González A; Bozec E; Clark AL; Cosmi F; Cuthbert J; Diez J; Edelmann F; Hazebroek M; Heymans S; Mariottoni B; Pellicori P; Petutschnigg J; Pieske B; Staessen JA; Verdonschot JAJ; Rossignol P; Cleland JGF; Zannad F
    Eur J Heart Fail; 2022 Sep; 24(9):1559-1568. PubMed ID: 35703355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation.
    Tziakas DN; Chalikias GK; Papanas N; Stakos DA; Chatzikyriakou SV; Maltezos E
    Europace; 2007 Aug; 9(8):589-96. PubMed ID: 17485436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation.
    Zhao F; Zhang S; Chen Y; Gu W; Ni B; Shao Y; Wu Y; Qin J
    BMC Cardiovasc Disord; 2014 Nov; 14():167. PubMed ID: 25422138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinus rhythm restoration affects collagen turnover in patients with persistent atrial fibrillation.
    Kallergis EM; Goudis CA; Kanoupakis EM; Mavrakis HE; Maliaraki NE; Tzanakis N; Vardas PE
    Europace; 2014 Dec; 16(12):1726-30. PubMed ID: 25142742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.
    Ravassa S; López B; Ferreira JP; Girerd N; Bozec E; Pellicori P; Mariottoni B; Cosmi F; Hazebroek M; Verdonschot JAJ; Cuthbert J; Petutschnigg J; Moreno MU; Heymans S; Staessen JA; Pieske B; Edelmann F; Clark AL; Cleland JGF; Zannad F; Díez J; González A;
    Eur J Heart Fail; 2022 Feb; 24(2):321-331. PubMed ID: 34841615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.
    Cleland JGF; Ferreira JP; Mariottoni B; Pellicori P; Cuthbert J; Verdonschot JAJ; Petutschnigg J; Ahmed FZ; Cosmi F; Brunner La Rocca HP; Mamas MA; Clark AL; Edelmann F; Pieske B; Khan J; McDonald K; Rouet P; Staessen JA; Mujaj B; González A; Diez J; Hazebroek M; Heymans S; Latini R; Grojean S; Pizard A; Girerd N; Rossignol P; Collier TJ; Zannad F;
    Eur Heart J; 2021 Feb; 42(6):684-696. PubMed ID: 33215209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation.
    Ravassa S; Ballesteros G; López B; Ramos P; Bragard J; González A; Moreno MU; Querejeta R; Vives E; García-Bolao I; Díez J
    J Am Coll Cardiol; 2019 Apr; 73(12):1398-1410. PubMed ID: 30922470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.
    Ferreira JP; Cleland JG; Girerd N; Rossignol P; Pellicori P; Cosmi F; Mariottoni B; González A; Diez J; Solomon SD; Claggett B; Pfeffer MA; Pitt B; Petutschnigg J; Pieske B; Edelmann F; Zannad F
    Int J Cardiol; 2023 Apr; 377():86-88. PubMed ID: 36738846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of Collagen Carboxy-Terminal Propeptide and Telopeptide to Predict Disturbances of Long-Term Mortality in Patients ≥60 Years With Heart Failure and Reduced Ejection Fraction.
    Löfsjögård J; Kahan T; Díez J; López B; González A; Ravassa S; Mejhert M; Edner M; Persson H
    Am J Cardiol; 2017 Jun; 119(12):2042-2048. PubMed ID: 28464988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy.
    Chung YW; Yang YH; Wu CK; Yu CC; Juang JM; Wang YC; Tsai CT; Lin LY; Lai LP; Hwang JJ; Chiang FT; Chen PC; Lin JL
    Int J Cardiol; 2016 Jan; 202():962-6. PubMed ID: 26323866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating biomarkers of collagen type I metabolism mark the right ventricular fibrosis and adverse markers of clinical outcome in adults with repaired tetralogy of Fallot.
    Chen CA; Tseng WY; Wang JK; Chen SY; Ni YH; Huang KC; Ho YL; Chang CI; Chiu IS; Su MY; Yu HY; Lin MT; Lu CW; Wu MH
    Int J Cardiol; 2013 Sep; 167(6):2963-8. PubMed ID: 22999338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade.
    Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; Marwick TH
    Heart; 2013 Mar; 99(5):320-6. PubMed ID: 23343682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating adiponectin levels in patients with atrial fibrillation.
    Shimano M; Shibata R; Tsuji Y; Kamiya H; Uchikawa T; Harata S; Muto M; Ouchi N; Inden Y; Murohara T
    Circ J; 2008 Jul; 72(7):1120-4. PubMed ID: 18577821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
    Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
    Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker and imaging responses to spironolactone in subclinical diabetic cardiomyopathy.
    Jellis CL; Sacre JW; Wright J; Jenkins C; Haluska B; Jeffriess L; Martin J; Marwick TH
    Eur Heart J Cardiovasc Imaging; 2014 Jul; 15(7):776-86. PubMed ID: 24472731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.